<p>Biopsies of castration resistant prostate cancer metastases were subjected to whole genome sequencing (WGS), along with RNA-sequencing (RNA-Seq). The overarching goal of the study is to illuminate molecular mechanisms of acquired resistance to therapeutic agents, and particularly androgen signaling inhibitors, in the treatment of metastatic castration resistant prostate cancer (mCRPC).</p>

Genomic Characterization of Metastatic Castration Resistant Prostate    Cancer

Prostatic Neoplasms, Castration-Resistant study with Bisulfite-Seq data on CRDC (101 participants)